Triple-negative breast cancer (TNBC) is a molecular subtype of breast cancer with negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) [28]. Here, ESR1 is linked to breast carcinoma.